PubRank

R L Darley

Author PubWeight™ 12.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD200 as a prognostic factor in acute myeloid leukaemia. Leukemia 2007 1.49
2 Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia. Leukemia 2007 1.29
3 CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemia. Leukemia 2011 1.07
4 Expression of AML1-ETO in human myelomonocytic cells selectively inhibits granulocytic differentiation and promotes their self-renewal. Leukemia 2004 0.98
5 Increased CD200 expression in acute myeloid leukemia is linked with an increased frequency of FoxP3+ regulatory T cells. Leukemia 2012 0.91
6 Expression of CD200 on AML blasts directly suppresses memory T-cell function. Leukemia 2012 0.86
7 γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin. Leukemia 2012 0.85
8 OGG1 is a novel prognostic indicator in acute myeloid leukaemia. Oncogene 2009 0.83
9 The molecular basis of myelodysplastic syndromes. Haematologica 1997 0.78
10 Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells. Leuk Res 2000 0.78
11 RUNX1-ETO deregulates the proliferation and growth factor responsiveness of human hematopoietic progenitor cells downstream of the myeloid transcription factor, MYCT1. Leukemia 2011 0.77
12 Aberrant expression of p21RAS but not p120GAP is a common feature of myelodysplasia. Leukemia 1995 0.77
13 Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process. Cancer Res 1998 0.77
14 Oncogenic RAS genes impair erythroid differentiation of erythroleukaemia cells. Leuk Res 1997 0.76
15 Upregulation of p21 RAS levels in HL-60 cells during differentiation induction with DMSO, all-trans-retinoic acid and TPA. Leuk Res 1995 0.75
16 The sensitivity of human cells expressing RUNX1-RUNX1T1 to chemotherapeutic agents. Leukemia 2006 0.75
17 γ-Catenin is expressed throughout normal human hematopoietic development and is required for normal PU.1-dependent monocyte differentiation. Leukemia 2013 0.75
18 The loss of class II MHC antigen expression by ras-transformed murine fibroblasts passaged as tumours correlates with increased tumorigenicity but is not mediated by T cells. Cancer Immunol Immunother 1992 0.75